NN INC

NN, Inc. has released an updated investor presentation detailing its strategic focus on high-value markets and its "Breakout Profitable Growth" program. The company is benefiting from multi-year initiatives to drive profitable growth in targeted sectors such as Data Center & Electrical Grid, Defense & Electronics, and Medical. The presentation also includes updated financial guidance for 2026, with raised midpoints for Net Sales to $470 million, Adjusted EBITDA to $60 million, and New Business Wins to $90 million. Key growth areas like Data Center and Electric Grid, Defense and Electronics, and Medical Products are showing strong momentum and targeted expansion plans.

NN, Inc. reported a significant improvement in its financial performance for the second quarter of 2026, with net sales increasing by 19.3% to $128.7 million and net loss reducing by 72% to $2.3 million. The company achieved positive operating income of $1.0 million for the quarter, a notable turnaround from a loss in the prior year. Cash flow from operating activities also saw substantial improvement year-to-date, though long-term debt increased and the Mobile Solutions segment continued to report an operating loss.

NN, Inc. reported strong second-quarter 2026 results, with net sales increasing 19.3% to $128.7 million and adjusted net income surging 636.5% to $5.5 million. The company also announced a significant refinancing of its preferred stock, paying off approximately $89 million, which was enabled by sustained multi-year performance. Following these strong results, NN raised its full-year 2026 guidance for net sales and adjusted EBITDA, driven by its 5 Pillar growth program.

NN, Inc. announced a three-part transaction to address its $124 million Series D preferred stock held by investment funds managed by Morgan Stanley Tactical Value. The company paid off $70 million using cash from a previously announced PIPE transaction, exchanged approximately $19 million for common stock, and refinanced the remaining $35 million at a reduced 10% interest rate for one year. This strategic move significantly deleverages NN's balance sheet and is expected to set the stage for refinancing its secured Term Loan debt at a lower cost of capital, enhancing shareholder value.

NN, Inc. and Legion Partners Asset Management, LLC entered into a letter agreement on July 29, 2026. This agreement accelerates the vesting of 49,079 restricted stock shares for former director Raymond T. White, who resigned on July 20, 2026. Additionally, Legion Partners irrevocably waived their right to appoint a replacement director under the previous Cooperation Agreement, thereby terminating NN Inc.'s obligations under Section 1 of that agreement.

NN, Inc. granted performance share units (PSUs) to its President and CEO Harold Bevis (250,000), COO Tim French (140,000), and SVP & CFO Chris Bohnert (110,000) on July 23, 2026. These PSUs are designed to reward past performance, motivate strategic achievement, and retain leadership. Vesting is tied to performance goals including cumulative adjusted EBITDA, free cash flow, net sales, and total shareholder return over a three-year period, with payouts ranging from 0% to 200% of target.

NN Inc. announced that Raymond T. White resigned from its Board of Directors, effective July 20, 2026. The company stated that Mr. White's departure was not due to any disagreements with the company, its management, or the Board.

NN, Inc. announced its successful entry into the Tier 1 contract manufacturing industry for firearm components in the U.S. market. The company has secured a contract to mass produce completed firearms products for a leading provider, a new business expected to add between $12 million to $15 million in annual sales, starting in Q3 2026 and ramping through 2028. This strategic move is part of NN's Defense & Electronics growth program, which currently has nearly $60 million in sales and a five-year goal to reach $100 million.

NN, Inc. announced a significant expansion in its Medical Products business, securing initial purchase orders to manufacture critical components for a leading robotic-assisted surgery platform. This follows a multi-year investment program and a successful full-facility audit at its Kentwood, Michigan plant, establishing a new medical certification. The company's medical new business pipeline has increased by approximately $25 million, now totaling around $75 million, contributing to a corporate new business pipeline exceeding $750 million. This move positions NN to capitalize on the rapidly growing robotic-assisted surgery market.

NN Inc. has entered into a Securities Purchase Agreement with institutional investors for a private placement of common stock. The company will sell 24,509,804 shares at $3.06 per share, expecting to raise $75.0 million in gross proceeds. The closing is anticipated around July 2, 2026, and the company has also agreed to file a registration statement for the resale of these shares within 45 days.